GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kobayashi Pharmaceutical Co Ltd (FRA:KOY) » Definitions » Shiller PE Ratio

Kobayashi Pharmaceutical Co (FRA:KOY) Shiller PE Ratio : 23.77 (As of May. 25, 2024)


View and export this data going back to . Start your Free Trial

What is Kobayashi Pharmaceutical Co Shiller PE Ratio?

As of today (2024-05-25), Kobayashi Pharmaceutical Co's current share price is €32.80. Kobayashi Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 was €1.38. Kobayashi Pharmaceutical Co's Shiller PE Ratio for today is 23.77.

The historical rank and industry rank for Kobayashi Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

FRA:KOY' s Shiller PE Ratio Range Over the Past 10 Years
Min: 20.97   Med: 45.71   Max: 67.8
Current: 23.76

During the past years, Kobayashi Pharmaceutical Co's highest Shiller PE Ratio was 67.80. The lowest was 20.97. And the median was 45.71.

FRA:KOY's Shiller PE Ratio is ranked worse than
61.5% of 1078 companies
in the Consumer Packaged Goods industry
Industry Median: 18.765 vs FRA:KOY: 23.76

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Kobayashi Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was €0.081. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €1.38 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Kobayashi Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Kobayashi Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kobayashi Pharmaceutical Co Shiller PE Ratio Chart

Kobayashi Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.06 67.31 44.59 41.33 28.72

Kobayashi Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.26 34.55 28.47 28.72 21.02

Competitive Comparison of Kobayashi Pharmaceutical Co's Shiller PE Ratio

For the Household & Personal Products subindustry, Kobayashi Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kobayashi Pharmaceutical Co's Shiller PE Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kobayashi Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Kobayashi Pharmaceutical Co's Shiller PE Ratio falls into.



Kobayashi Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Kobayashi Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=32.80/1.38
=23.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kobayashi Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Kobayashi Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.081/107.2000*107.2000
=0.081

Current CPI (Mar. 2024) = 107.2000.

Kobayashi Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.213 98.000 0.233
201409 0.268 98.500 0.292
201412 0.436 97.900 0.477
201503 0.167 97.900 0.183
201506 0.255 98.400 0.278
201509 0.284 98.500 0.309
201512 0.594 98.100 0.649
201603 0.103 97.900 0.113
201606 0.548 98.100 0.599
201609 0.315 98.000 0.345
201612 0.637 98.400 0.694
201703 0.363 98.100 0.397
201706 0.365 98.500 0.397
201709 0.451 98.800 0.489
201712 0.390 99.400 0.421
201803 0.370 99.200 0.400
201806 0.375 99.200 0.405
201809 0.593 99.900 0.636
201812 0.422 99.700 0.454
201903 0.371 99.700 0.399
201906 0.472 99.800 0.507
201909 0.759 100.100 0.813
201912 0.411 100.500 0.438
202003 0.403 100.300 0.431
202006 0.473 99.900 0.508
202009 0.724 99.900 0.777
202012 0.400 99.300 0.432
202103 0.359 99.900 0.385
202106 0.410 99.500 0.442
202109 0.691 100.100 0.740
202112 0.482 100.100 0.516
202203 0.344 101.100 0.365
202206 0.386 101.800 0.406
202209 0.620 103.100 0.645
202212 0.505 104.100 0.520
202303 0.331 104.400 0.340
202306 0.365 105.200 0.372
202309 0.636 106.200 0.642
202312 0.411 106.800 0.413
202403 0.081 107.200 0.081

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kobayashi Pharmaceutical Co  (FRA:KOY) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Kobayashi Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Kobayashi Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kobayashi Pharmaceutical Co (FRA:KOY) Business Description

Traded in Other Exchanges
Address
KDX Kobayashi Doshomachi Building, 4-4-10 Doshomachi, Chuo-ku, Osaka, JPN, 541-0045
Kobayashi Pharmaceutical Co Ltd is a consumer product company focusing on niche markets. Its portfolio ranges from OTC pharmaceuticals, household products, to body warmers, and skincare. Kobayashi mainly sells its products in drugstores, convenience stores, and general merchandise stores, or GMSes. It has a geographical presence in Japan and is expanding overseas business in the U.S., China, and Southeast Asia.

Kobayashi Pharmaceutical Co (FRA:KOY) Headlines

No Headlines